RxSight, Inc. (RXST)
RXST Stock Price Chart
Explore RxSight, Inc. interactive price chart. Choose custom timeframes to analyze RXST price movements and trends.
RXST Company Profile
Discover essential business fundamentals and corporate details for RxSight, Inc. (RXST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 Jul 2021
Employees
498.00
Website
https://www.rxsight.comCEO
Ronald M. Kurtz
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
RXST Financial Timeline
Browse a chronological timeline of RxSight, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.19, while revenue estimate is $25.63M.
Earnings released on 7 Aug 2025
EPS came in at -$0.08 surpassing the estimated -$0.10 by +20.00%, while revenue for the quarter reached $33.64M , beating expectations by +30.64%.
Earnings released on 7 May 2025
EPS came in at -$0.03 surpassing the estimated -$0.04 by +25.00%, while revenue for the quarter reached $37.90M , missing expectations by -0.03%.
Earnings released on 25 Feb 2025
EPS came in at $0.03 falling short of the estimated $0.10 by -70.00%, while revenue for the quarter reached $40.21M , beating expectations by +1.09%.
Earnings released on 7 Nov 2024
EPS came in at -$0.16 surpassing the estimated -$0.25 by +36.00%, while revenue for the quarter reached $45.41M , beating expectations by +12.49%.
Earnings released on 5 Aug 2024
EPS came in at -$0.16 surpassing the estimated -$0.22 by +27.27%, while revenue for the quarter reached $34.89M , missing expectations by -0.44%.
Earnings released on 6 May 2024
EPS came in at -$0.12 surpassing the estimated -$0.17 by +29.41%, while revenue for the quarter reached $29.51M , beating expectations by +7.08%.
Earnings released on 28 Feb 2024
EPS came in at -$0.26 surpassing the estimated -$0.36 by +27.78%, while revenue for the quarter reached $28.58M , beating expectations by +4.19%.
Earnings released on 9 Nov 2023
EPS came in at -$0.35 surpassing the estimated -$0.42 by +16.67%, while revenue for the quarter reached $30.67M , beating expectations by +19.05%.
Earnings released on 7 Aug 2023
EPS came in at -$0.40 surpassing the estimated -$0.47 by +14.89%, while revenue for the quarter reached $20.81M , beating expectations by +8.22%.
Earnings released on 9 May 2023
EPS came in at -$0.42 surpassing the estimated -$0.52 by +19.23%, while revenue for the quarter reached $17.49M , missing expectations by -9.05%.
Earnings released on 6 Mar 2023
EPS came in at -$0.56 surpassing the estimated -$0.72 by +22.22%, while revenue for the quarter reached $16.09M , missing expectations by -1.18%.
Earnings released on 7 Nov 2022
EPS came in at -$0.61 surpassing the estimated -$0.70 by +12.86%, while revenue for the quarter reached $12.62M , beating expectations by +14.91%.
Earnings released on 8 Aug 2022
EPS came in at -$0.50 surpassing the estimated -$0.68 by +26.47%, while revenue for the quarter reached $11.36M , beating expectations by +7.68%.
Earnings released on 5 May 2022
EPS came in at -$0.54 surpassing the estimated -$0.56 by +3.57%, while revenue for the quarter reached $8.94M , beating expectations by +22.17%.
Earnings released on 8 Mar 2022
EPS came in at -$0.47 surpassing the estimated -$0.58 by +18.97%, while revenue for the quarter reached $8.43M , beating expectations by +10.30%.
Earnings released on 10 Nov 2021
EPS came in at -$0.65 falling short of the estimated -$0.61 by -6.56%, while revenue for the quarter reached $5.79M , beating expectations by +5.88%.
Earnings released on 9 Sept 2021
EPS came in at -$3.24 falling short of the estimated -$0.68 by -376.47%, while revenue for the quarter reached $4.90M .
Earnings released on 30 Jul 2021
EPS came in at -$0.36 , while revenue for the quarter reached $3.48M .
Earnings released on 31 Dec 2020
EPS came in at $1.38 , while revenue for the quarter reached $4.91M .
Earnings released on 30 Sept 2020
EPS came in at $1.61 , while revenue for the quarter reached $4.17M .
RXST Stock Performance
Access detailed RXST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.